Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1987 1
1990 1
1991 1
1994 1
1996 1
1997 3
1998 1
1999 1
2000 1
2001 4
2002 1
2003 3
2004 1
2005 2
2006 3
2007 1
2008 1
2009 1
2010 1
2011 6
2012 4
2013 1
2014 2
2015 4
2016 3
2017 1
2018 7
2019 4
2020 3
2021 1
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita.
Prost-Squarcioni C, Caux F, Schmidt E, Jonkman MF, Vassileva S, Kim SC, Iranzo P, Daneshpazhooh M, Terra J, Bauer J, Fairley J, Hall R, Hertl M, Lehman JS, Marinovic B, Patsatsi A, Zillikens D; International Bullous Diseases Group; Werth V, Woodley DT, Murrell DF. Prost-Squarcioni C, et al. Br J Dermatol. 2018 Jul;179(1):30-41. doi: 10.1111/bjd.16138. Epub 2018 May 8. Br J Dermatol. 2018. PMID: 29165796
BACKGROUND: Epidermolysis bullosa acquisita (EBA) is a complex autoimmune bullous disease disease with variable clinical presentations and multiple possible diagnostic tests, making an international consensus on the diagnosis of EBA essential. ...
BACKGROUND: Epidermolysis bullosa acquisita (EBA) is a complex autoimmune bullous disease disease with variable clinica …
Treatment Update of Autoimmune Blistering Diseases.
Kridin K, Ahn C, Huang WC, Ansari A, Sami N. Kridin K, et al. Dermatol Clin. 2019 Apr;37(2):215-228. doi: 10.1016/j.det.2018.12.003. Epub 2019 Feb 14. Dermatol Clin. 2019. PMID: 30850044 Review.
The last 2 decades has seen the use of rituximab become a conventional treatment in the therapeutic armamentarium of AIBDs, leading to its Food and Drug Administration indication for pemphigus vulgaris in 2018. We review the current updated data on the use of rituximab inc …
The last 2 decades has seen the use of rituximab become a conventional treatment in the therapeutic armamentarium of AIBDs, leading t …
Inherited epidermolysis bullosa: new diagnostic criteria and classification.
Intong LR, Murrell DF. Intong LR, et al. Clin Dermatol. 2012 Jan-Feb;30(1):70-7. doi: 10.1016/j.clindermatol.2011.03.012. Clin Dermatol. 2012. PMID: 22137229 Review.
Epidermolysis bullosa (EB) is a group of inherited, mechanobullous disorders caused by mutations in various structural proteins in the skin. ...
Epidermolysis bullosa (EB) is a group of inherited, mechanobullous disorders caused by mutations in various structural protein …
Management of epidermolysis bullosa acquisita.
Intong LR, Murrell DF. Intong LR, et al. Dermatol Clin. 2011 Oct;29(4):643-7. doi: 10.1016/j.det.2011.06.020. Epub 2011 Aug 15. Dermatol Clin. 2011. PMID: 21925011 Review.
Epidermolysis bullosa acquisita is a rare and debilitating autoimmune mucocutaneous blistering disease caused by autoantibodies directed against type VII collagen or anchoring fibrils in the subepidermal basement membrane zone. ...
Epidermolysis bullosa acquisita is a rare and debilitating autoimmune mucocutaneous blistering disease caused by autoan …
Treatment of Autoimmune Bullous Disorders in Pregnancy.
Kushner CJ, Concha JSS, Werth VP. Kushner CJ, et al. Am J Clin Dermatol. 2018 Jun;19(3):391-403. doi: 10.1007/s40257-018-0342-0. Am J Clin Dermatol. 2018. PMID: 29392620 Review.
Autoimmune bullous diseases (AIBD), including pemphigus, bullous pemphigoid, epidermolysis bullosa acquisita, mucous membrane pemphigoid, and pemphigoid gestationis, pose significant therapeutic challenges, especially in pregnant and post-partum breast …
Autoimmune bullous diseases (AIBD), including pemphigus, bullous pemphigoid, epidermolysis bullosa acquisita, mucous me …
A systematic review on efficacy, safety and treatment durability of intravenous immunoglobulin in autoimmune bullous dermatoses: Special focus on indication and combination therapy.
Kianfar N, Dasdar S, Daneshpazhooh M, Aryanian Z, Goodarzi A. Kianfar N, et al. Exp Dermatol. 2023 Jul;32(7):934-944. doi: 10.1111/exd.14829. Epub 2023 May 7. Exp Dermatol. 2023. PMID: 37150538 Review.
The use of IVIg alone or combined with rituximab was reported in 500 patients with pemphigus, 82 patients with bullous pemphigoid, 146 patients with mucous membranes pemphigoid and 19 patients with epidermolysis bullosa acquisita. Disease remission with IVIg …
The use of IVIg alone or combined with rituximab was reported in 500 patients with pemphigus, 82 patients with bullous pemphigoid, 146 patie …
The diagnosis and treatment of autoimmune blistering skin diseases.
Schmidt E, Zillikens D. Schmidt E, et al. Dtsch Arztebl Int. 2011 Jun;108(23):399-405, I-III. doi: 10.3238/arztebl.2011.0399. Epub 2011 Jun 10. Dtsch Arztebl Int. 2011. PMID: 21712975 Free PMC article. Review.
BACKGROUND: Autoimmune blistering skin diseases are a heterogeneous group of disorders associated with autoantibodies that are directed against desmosomal structural proteins (in pemphigus diseases) or hemidesmosomal ones (in pemphigoid diseases and epidermolysis bullos …
BACKGROUND: Autoimmune blistering skin diseases are a heterogeneous group of disorders associated with autoantibodies that are directed agai …
Immune mechanism-targeted treatment of experimental epidermolysis bullosa acquisita.
Ludwig R. Ludwig R. Expert Rev Clin Immunol. 2015;11(12):1365-78. doi: 10.1586/1744666X.2015.1085801. Epub 2015 Oct 15. Expert Rev Clin Immunol. 2015. PMID: 26471717 Review.
Epidermolysis bullosa acquisita (EBA) is an autoimmune bullous dermatosis characterized by chronic mucocutaneous blistering caused by autoantibodies directed against type VII collagen. ...Model systems have significantly broadened our understanding of EBA pat …
Epidermolysis bullosa acquisita (EBA) is an autoimmune bullous dermatosis characterized by chronic mucocutaneous bliste …
Therapeutic approaches and targets for treatment of autoimmune bullous diseases.
Bardazzi F, Loi C, Chessa Marco A, Di Altobrando A, Filippi F, Lacava R, Viviani F, Balestri R, Leuzzi M, Sacchelli L. Bardazzi F, et al. Dermatol Ther. 2021 Sep;34(5):e15032. doi: 10.1111/dth.15032. Epub 2021 Jul 14. Dermatol Ther. 2021. PMID: 34145701 Review.
The common pathogenetic mechanism is the presence of autoantibodies targeting structural proteins of the skin and mucous membranes (demosomes and hemidesmosomes): in the case of pemphigus, the antigens are intraepidermal, whereas in the case of pemphigoid, dermatitis herpetiformi …
The common pathogenetic mechanism is the presence of autoantibodies targeting structural proteins of the skin and mucous membranes (demosome …
Current concepts in the treatment of epidermolysis bullosa acquisita.
Gürcan HM, Ahmed AR. Gürcan HM, et al. Expert Opin Pharmacother. 2011 Jun;12(8):1259-68. doi: 10.1517/14656566.2011.549127. Epub 2011 Jan 22. Expert Opin Pharmacother. 2011. PMID: 21254861 Review.
Patients who are resistant or develop side effects to conventional immunosuppressive therapy (CIST) have been treated with several other agents. AREAS COVERED: This review focuses on the clinical outcome in patients treated with a single drug or combination, and determines …
Patients who are resistant or develop side effects to conventional immunosuppressive therapy (CIST) have been treated with several ot …
66 results